Tag Archives | drug pricing

Weak NASDAQ Leaves Biotech Stocks Stalled…Update-1

Update-1 …March 18- Market jittery on potential global trade war, rising interest rate concerns and political risk. Also Sales to U.S. retailers fell 0.1% in February a 3 month slide. Biotechs are in a risk-off mode with a weak tape. Dow down 0.47%, NASDAQ down 0.2%, IBB down 0.98%, XBI down 1.56% Biotechs stocks were red across […]

Continue Reading 0

More Drug Pricing Headwinds for Biotech Just as Tape Improves: Update-1 M&A Uptick

Update 2/8/17 12N EST Biotech Stocks Perk Up on M&A Rumors PARP Inhibitor stocks- Clovis Oncology (CLVS) up 3%, Tesaro (TSRO) up 12.5%. IBB and XBI flattish. EXEL up 2.7%. INCY up 1.78%. GWPH up 3.9%. Also Foundation Medicine (FMI) is up over 10% to $24 with no news. GILD down 9.7% to $66: maybe […]

Continue Reading 0

Pfizer (PFE) Acquisition of Medivation (MDVN) Provides Support to Biotech Stocks…Update-1 IBB Down 3.36%

Update-1 After Close 8/24 IBB at 286.23 XBI down 4.34% XLV down 1.54%, NASDAQ down 0.81% Early Afternoon Reversal Kills Biotech Rally In Heavy Trading But Mylan is not a biotech Company?? The broad based rally in biotech stocks faded around 1P EDT Wednesday as investors were spooked by the recurring political theme of high […]

Continue Reading 0